Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Winn-Dixie Company helps provide more than 1 million meals to neighbors facing hunger during Hunger Action Month®
-
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
-
Infinix Launches GT NX Series Peripherals: Redefine Mobile Gaming Boundaries to Deliver Native Console-Grade Experience for Gamers
-
Vertical Aerospace Announces Review of Strategic Alternatives to Support Next Phase of Development; Appoints Jefferies as Financial Advisor
-
Redwire Selected for Space Systems Command’s $980 million NITE-STAR IDIQ Contract
-
Optimum Nutrition Brings Fiber Into the Protein Conversation with New 30G Ultra-Filtered Milk Protein Shake + Fiber
-
Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
-
Starboard Delivers Letter to Knife River
-
Elroy Air Announces Upsizing of PIPE Investments to $175 Million with Participation from Lockheed Martin Ventures
-
BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design
-
Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product
-
Taiga Launches OS-5 Software, Bringing Industry-First Geofencing its Electric Fleet
-
PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment
-
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
-
TRISO-X Completes Vertical Construction of TX-1 Fuel Fabrication Facility
-
NYC’s Top Chefs Take On Zero-Waste Dining for Mill’s 3rd Annual Make Food Not Waste Restaurant Week
-
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
-
It’s a Good Day, Connecticut: Kite Launches Line of Wellness-focused, Intentional Cannabis Products
-
Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to S
-
Bank of Botetourt Begins Trading on OTCQX Best Market
-
The Lovesac Company Announces Participation in Upcoming Investor Conference
-
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
-
Pasqal Reports First Half 2026 Financial Results
-
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
-
NOA Lithium Provides Update on 2026 Exploration Campaign and Provides Corporate Updates
-
BlackBerry Reports Second Quarter Fiscal Year 2027 Results
-
B2B Marketing Launches Propolis AI, a Specialist Intelligence Platform for B2B Marketers
-
JAGUAR URANIUM REPORTS RARE EARTH OXIDES ASSOCIATED WITH URANIUM-PHOSPHATE-VANADIUM MINERALIZATION AT THE BERLIN ASSET IN COLOMBIA
-
Dollar General Helps Families Stretch Holiday Budgets with Toy Deals, New Items, and Everyday Low Prices
-
NICHOLAS AIR Highlights Pilot Career Pathways at Auburn Business Aviation Days
-
/C O R R E C T I O N -- Basecamp Research/
-
BaazEX Enters the Asian Trading Market With a New Approach to Online Forex Trading
-
Middle-School Students from 101 Countries Visit Yangliuqing Historic Town in Tianjin
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Miami International Holdings Announces OCC Clearing Membership for its FCM
-
L&T Technology Services Partners with Cognite to Advance Engineering Intelligence with Industrial AI
-
Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema
-
U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes
-
RiverNorth Opportunities Fund, Inc. Announces Preliminary Results of Rights Offering
-
Majority of U.S. Consumers Now Use AI to Shop, NIQ Finds
-
Descartes Expands AI Innovation with Agent that Helps Reduce Global Trade Data Research and Analysis Time by Up to 90%
-
Eureka Ergonomic Introduces Royal Series, an Eight-Model Executive Chair Collection for Modern Workspaces
-
Top RuPay Credit Cards in India for UPI Payments (2026)
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Tacta Systems™ Expands Global Manufacturing Footprint With New Singapore Facility
-
Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors
-
Form 8.5 (EPT/RI)-SThree plc
-
Red Lake Gold Inc. Reports Annual General and Special Meeting Results
-
Gold Strike Completes 2026 Drill Program at the Florin Gold Project, Yukon
-
Knack RCM Unveils a Refreshed Brand for the Future of Specialty-Intelligent Revenue Cycle Management
